je.st
news
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
2014-06-11 16:23:49| Biotech - Topix.net
Encouraging single-agent CYRAMZA activity was observed, with meaningful improvements in key secondary endpoints of progression-free survival, overall response rate and time to progression.
Tags: results
iii
trial
phase
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||